Saturday 17 October 2026
Export CVRX’s income statement to Excel — free account
CVRx, Inc.
CVRX Healthcare Medical Devices
CVRx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $56.7 million, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 7.02%, free cash flow fell 11.2% and total debt rose 18.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.30
0.09
−6.47%
Follow CVRX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 4 | 5 |
+8 more TTM periods Free account |
| (133.44%) | (106.96%) | (96.59%) | (91.88%) | ||
| (49.06%) | (45.93%) | (44.76%) | (43.53%) | ||
ROIC |
(218.09%) | (204.26%) | (244.03%) | (254.15%) | |
Return on Tangible Assets |
(64.62%) | (58.89%) | (58.85%) | (52.49%) | |
Average Days of Receivables |
56.08 | 56.25 | 68.71 | 53.53 | |
Free Cash Flow per Share |
(1.55) | (1.52) | (1.56) | (1.49) | |
Free Cash Flow |
(41.05) | (40.15) | (40.75) | (38.98) | |
Capital Expenditures |
(0.60) | (0.59) | (0.58) | (0.56) | |
| Other line items | |||||
Cash ROIC |
(28.69%) | (25.11%) | (24.77%) | (21.35%) | |
Accounts Receivable Turnover |
7.39 | 6.52 | 5.68 | 6.49 | |
Accounts Payable Turnover |
2.32 | 2.84 | 2.59 | 2.52 | |
Inventory Turnover |
0.65 | 0.68 | 0.68 | 0.75 | |
Average Days of Payables |
176.64 | 134.05 | 168.34 | 152.51 | |
Days of Inventory on Hand |
594.03 | 554.59 | 536.02 | 478.96 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
20.20% | 19.80% | 19.65% | 19.54% | |
Selling, General and Administrative Expense of Revenue |
146.20% | 151.00% | 156.17% | 154.91% | |
Share Based Compensation of Revenue |
20.04% | 19.49% | 19.51% | 19.55% | |
Interest Coverage |
(8.07) | (8.44) | (8.80) | (8.49) | |
Operating CF/Net income |
0.78 | 0.75 | 0.75 | 0.74 | |
Depreciation/Fixed assets |
0.53 | 0.48 | 0.44 | 0.40 | |
Capex/Depreciation |
(0.55) | (0.56) | (0.58) | (0.57) | |
Revenue per Share |
2.31 | 2.24 | 2.17 | 2.14 | |
Operating CF per Share |
(1.53) | (1.50) | (1.54) | (1.47) | |
Capex per Share |
(0.02) | (0.02) | (0.02) | (0.02) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates